HR 5568
115th Congress
House
Health
Advanced technology and technological innovations
Congressional oversight
Drug safety, medical device, and laboratory regulation
Educational facilities and institutions
Government information and archives
Health programs administration and funding
Health technology, devices, supplies
Higher education
Manufacturing
Prescription drugs
Product development and innovation
Research administration and funding
Research and development
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018
Introduced: April 18, 2018
Introduced by:
Pallone, Frank
Democratic
· New Jersey
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 18, 2018
Introduced in House
Apr 18, 2018
Referred to the House Committee on Energy and Commerce.
Plain-English summary
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018
This bill authorizes the Food and Drug Administration to partner with institutions of higher education to designate them as National Centers of Excellence in Continuous Pharmaceutical Manufacturing for the purpose of studying and recommending improvements to the process of continuous manufacturing of medications. (Currently, most medications are manufactured in batches.)
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1
Cosponsors
1